Study of clinical and diagnostic parameters in patients with acute coronary syndrome who underwent COVID-19

The 2019 coronavirus infection pandemic (COVID-19) is widespread worldwide and is characterized by severe complications from the respiratory system, kidneys, liver, etc. The article presents an analysis of ACS in patients with COVID-19. It was revealed that in patients with coronavirus infection, acute coronary syndrome is characterized by a large number of complications and a high risk of death. The article presents the results of a study conducted by the authors on the study of acute coronary syndrome in patients who have undergone COVID-19. The study compares two groups of patients with ACS, depending on the presence of COVID-19 in the anamnesis. In the comparison groups, the analysis of the prevalence of risk factors for cardiovascular diseases was carried out: smoking, age, diabetes, obesity, dyslipidemia. The results of biochemical blood analysis and coagulogram were analyzed. It was found that patients with acute coronary syndrome who underwent COVID-19 were less likely to have risk factors for cardiovascular diseases. Patients with acute coronary syndrome who underwent COVID-19 had lower blood glucose, cholesterol, VLDL, triglycerides and higher blood clotting rates. As a result of the study, it was revealed that COVID-19 is an independent risk factor for the development of acute coronary syndrome against the background of multiple coronary vascular lesions.

1. Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May; 8(5):475-48L doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr; 8(4): e26. PMID: 32105632; PMCID: PMC7102538.

2. Wadhera R. K., Shen C., Gondi S., Chen S., Kazi D. S., Yeh R. W. Cardiovascular Deaths During the COVID-19 Pandemic in the United States. J Am Coll Cardiol. 2021 Jan 19;77(2):159-169. doi: 10.1016/j.jacc.2020.10.055. PMID: 33446309; PMCID: PMC 7800141..

3. Wadhera R. K., Shen C., Gondi S., Chen S., Kazi D. S., Yeh R. W. Cardiovascular Deaths During the COVID-19 Pandemic in the United States. J Am Coll Cardiol. 2021 Jan 19;77(2):159-169. doi: 10.1016/j.jacc.2020.10.055. PMID: 33446309; PMCID: PMC 7800141.

4. Huang B., Xu C., Liu H., Deng W., Yang Z., Wan J., et al. In-Hospital Management and Outcomes of Acute Myocardial Infarction Before and During the Coronavirus Disease 2019 Pandemic. J Cardiovasc Pharmacol. 2020 Nov; 76(5):540-548. doi: 10.1097/FJC.0000000000000909. PMID: 33170591.

5. Mafham M. M., Spata E., Goldacre R., Gair D., Curnow P., Bray M., et al. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet. 2020 Aug 8;396(10248):381-389. doi: 10.1016/S0140-6736(20)31356-8. Epub 2020 Jul 14. PMID: 32679111; PMCID: PMC7429983.

6. Kite T. A., Ludman P. F., Gale C. P., Wu J., Caixeta A., Mansourati J., et al. International COVID-ACS Registry Investigators. International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19. J Am Coll Cardiol. 2021 May 25;77(20):2466-2476. doi: 10.1016/j.jacc.2021.03.309. PMID: 34016259; PMCID: PMC 8128002.

7. Abate S. M., Mantefardo B., Nega S., Chekole Y. A., Basu B., Ali S. A., et al. Global burden of acute myocardial injury associated with COVID-19: A systematic review, meta-analysis, and meta-regression. Ann Med Surg (Lond). 2021 Aug; 68:102594. doi: 10.1016/j.amsu.2021.102594. Epub 2021 Jul 28. PMID: 34336202; PMCID: PMC8316689.

8. Azul Freitas A., Baptista R., Gongalves V., Ferreira C., Milner J., Lourengo C., et al. Impact of SARS-CoV-2 pandemic on ST-elevation myocardial infarction admissions and outcomes in a Portuguese primary percutaneous coronary intervention center Preliminary Data. Rev Port Cardiol (Engl Ed). 2021 Jul; 40(7):465-471. doi: 10.1016/j.repce.2021.07.014. PMID: 34274091; PMCID: PMC8278193.

9. Hamadeh A., Aldujeli A., Briedis K., Tecson K. M., Sanz-Sanchez J., Al Dujeili M., et al. Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2020 Sep 15;131:1-6. doi: 10.1016/j.amjcard.2020.06.063. Epub 2020 Jul 3. PMID: 32732010; PMCID: PMC 7333635.

10. Choudry F. A., Hamshere S. M., Rathod K. S., Akhtar M. M., Archbold RA, Guttmann OP, et al. High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2020 Sep 8;76(10):1168-1176. doi: 10.1016/j.jacc.2020.07.022. Epub 2020 Jul 14. PMID: 32679155; PMCID: PMC7833185.

11. Sianos G., Morel M. A., Kappetein A. P., Monce M. C., Colombo A., Dawkins K., et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005 Aug; 1(2):219-27. PMID: 19758907.

12. Ahmed Mokhtar El Kersh, Ahmed Ashraf Reda, Mohamed Gamal El Hadad, Khaled Hussein El-Sharnouby. Correlation between SYNTAX Score and Pattern of Risk Factors in Patients Referred for Coronary Angiography in Cardiology Department, Menoufia University World Journal of Cardiovascular Diseases January 2018. 08(08):431-439. DOI:10.4236/wjcd.2018.88042.

13. Ndrepepa G., Tada T., Fusaro M., Cassese S., King L., Hadamitzky M., et al. Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease. Clin Res Cardiol. 2012 Dec; 101(12):1003-11. doi: 10.1007/s00392-012-0490-9. Epub 2012 Jul 8. PMID: 22772817.

14. Гаврилова Н. Е., Метельская В. А., Перова Н. В., Яровая Е. Б., Бойцов С. А., Мазаев В. П. Выбор метода количественной оценки поражения коронарных артерий на основе сравнительного анализа ангиографических шкал. Российский кардиологический журнал.-2014.-6 (110).-С 24-30. [Gavrilova N. E., Metelskaya V. A., Perova N. V., Yarovaya E. B., Boytsov S. A., Mazaev V. P. Vybor metoda kolichestvennoj ocenki porazheniya koronarnyh arterj na osnove sravnitel’nogo analiza angiograficheskih shkal. Rossijskij kardiologicheskij zhurnal.-2014.-6 (110).-S. 24-30.]

15. Gale C. P. Patient response, treatments, and mortality for acute myocardial infarction during the COVID-19 pandemic. Eur Heart J Qual Care Clin Outcomes. 2021 May 3;7(3):238-246. doi: 10.1093/ehjqcco/qcaa062. PMID: 32730620; PMCID: PMC 7454506.

16. Asakura H., Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2021 Jan;113(1):45-57. doi: 10.1007/s12185-020-03029-y. Epub 2020 Nov 7. PMID: 33161508; PMCID: PMC7648664.

17. Hanff T. C., Mohareb A. M., Gir J., Cohen J. B., Chirinos J. A. Thrombosis in COVID-19. Am J Hematol. 2020 Dec;95(12):1578-1589. doi: 10.1002/ajh.25982. Epub 2020 Sep 16. PMID: 32857878; PMCID: PMC7674272.

18. Chen L., Li X., Chen M., Feng Y., Xiong C.. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020 May 1;116(6):1097-1100. doi: 10.1093/cvr/cvaa078. Erratum in: Cardiovasc Res. 2020 Oct 1;116(12):1994. PMID: 32227090; PMCID: PMC7184507.

19. Madjid M., Safavi-Naeini P., Solomon S. D., Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020 Jul 1;5(7):831-840. doi: 10.1001/jamacardio.2020.1286. PMID: 32219363.

20. Guo T., Fan Y., Chen M., Wu X., lhang L., He T. et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017. Erratum in: JAMA Cardiol. 2020 Jul 1;5(7):848. PMID: 32219356; PMCID: PMC7101506.